Loading…

Local administration of WP9QY (W9) peptide promotes bone formation in a rat femur delayed-union model

The WP9QY peptide (W9) consists of nine amino acids. It binds to RANKL and blocks RANKL-induced increases in bone resorption and osteoclastogenesis. W9 has a unique effect on the coupling mechanism between osteoclasts and osteoblasts, which promotes bone formation while working to suppress bone reso...

Full description

Saved in:
Bibliographic Details
Published in:Journal of bone and mineral metabolism 2018-07, Vol.36 (4), p.383-391
Main Authors: Sawa, Mikiya, Wakitani, Shigeyuki, Kamei, Naosuke, Kotaka, Shinji, Adachi, Nobuo, Ochi, Mitsuo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c589t-82eae53e0634c188836910ec8e02f18698a6e20f82fa95106c9c597da6c6aa783
cites cdi_FETCH-LOGICAL-c589t-82eae53e0634c188836910ec8e02f18698a6e20f82fa95106c9c597da6c6aa783
container_end_page 391
container_issue 4
container_start_page 383
container_title Journal of bone and mineral metabolism
container_volume 36
creator Sawa, Mikiya
Wakitani, Shigeyuki
Kamei, Naosuke
Kotaka, Shinji
Adachi, Nobuo
Ochi, Mitsuo
description The WP9QY peptide (W9) consists of nine amino acids. It binds to RANKL and blocks RANKL-induced increases in bone resorption and osteoclastogenesis. W9 has a unique effect on the coupling mechanism between osteoclasts and osteoblasts, which promotes bone formation while working to suppress bone resorption. In this study, with the aim of clinical application of W9 for fracture treatment, we aimed to clarify the bone repair-promoting effect of W9 when administered locally to a rat femur model of delayed union. Using Sprague–Dawley rats, a model of delayed union was created in the right femur by cauterizing the periosteum. Injection of W9 (1 mg in 100 μl) or phosphate-buffered saline (PBS) (100 μl) at the fracture site was performed at the operation and every week thereafter until death (sacrifice). The bone union rate was 14% in the PBS group and 57% in the W9 group at 8 weeks postoperatively. The X-ray score of the W9 group was significantly higher than that of the PBS group at 8 weeks postoperatively. When bone morphometry was analyzed by micro-computed tomography (CT), total callus volume (TV) and mineralized callus bone volume (BV) were measured. TV showed no significant difference between the two groups, but BV/TV was significantly higher in the W9 group. This finding suggests that local administration of W9 can promote bone maturation from callus and can be considered to contribute to fracture healing. These results reveal that W9 has an effect on fractures of promoting healing and could be applied as a fracture treatment.
doi_str_mv 10.1007/s00774-017-0852-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1914850023</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1914850023</sourcerecordid><originalsourceid>FETCH-LOGICAL-c589t-82eae53e0634c188836910ec8e02f18698a6e20f82fa95106c9c597da6c6aa783</originalsourceid><addsrcrecordid>eNp1kUtr3DAUhUVpaCaPH9BNEXSTLJReydZrWUKbBAaSQMOQlVDk6-JgW1PJXuTfR4OnLQSykRD3O0eXcwj5zOGCA-hvuRy6ZsA1AyMFkx_IiteVZFJB_ZGswPKaGa3tITnK-RkKKDX_RA6FUQoqrVcE1zH4nvpm6MYuT8lPXRxpbOnmzt4_0rONPadb3E5dg3Sb4hAnzPQpjkjbmIaF7kbqaVHSFoc50QZ7_4INm8fdcIjlfUIOWt9nPN3fx-Th549fl9dsfXt1c_l9zYI0dmJGoEdZIaiqDtwYUynLAYNBEC03yhqvUEBrROut5KCCDdLqxqugvNemOiZni29Z9c-MeXJDlwP2vR8xztnxEoiRAKIq6Nc36HOc01i2cwJUCUooqQvFFyqkmHPC1m1TN_j04ji4XQdu6cCVaN2uAyeL5sveeX4asPmn-Bt6AcQC5DIaf2P6__X7rq84po_Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2061752657</pqid></control><display><type>article</type><title>Local administration of WP9QY (W9) peptide promotes bone formation in a rat femur delayed-union model</title><source>Springer Nature</source><creator>Sawa, Mikiya ; Wakitani, Shigeyuki ; Kamei, Naosuke ; Kotaka, Shinji ; Adachi, Nobuo ; Ochi, Mitsuo</creator><creatorcontrib>Sawa, Mikiya ; Wakitani, Shigeyuki ; Kamei, Naosuke ; Kotaka, Shinji ; Adachi, Nobuo ; Ochi, Mitsuo</creatorcontrib><description>The WP9QY peptide (W9) consists of nine amino acids. It binds to RANKL and blocks RANKL-induced increases in bone resorption and osteoclastogenesis. W9 has a unique effect on the coupling mechanism between osteoclasts and osteoblasts, which promotes bone formation while working to suppress bone resorption. In this study, with the aim of clinical application of W9 for fracture treatment, we aimed to clarify the bone repair-promoting effect of W9 when administered locally to a rat femur model of delayed union. Using Sprague–Dawley rats, a model of delayed union was created in the right femur by cauterizing the periosteum. Injection of W9 (1 mg in 100 μl) or phosphate-buffered saline (PBS) (100 μl) at the fracture site was performed at the operation and every week thereafter until death (sacrifice). The bone union rate was 14% in the PBS group and 57% in the W9 group at 8 weeks postoperatively. The X-ray score of the W9 group was significantly higher than that of the PBS group at 8 weeks postoperatively. When bone morphometry was analyzed by micro-computed tomography (CT), total callus volume (TV) and mineralized callus bone volume (BV) were measured. TV showed no significant difference between the two groups, but BV/TV was significantly higher in the W9 group. This finding suggests that local administration of W9 can promote bone maturation from callus and can be considered to contribute to fracture healing. These results reveal that W9 has an effect on fractures of promoting healing and could be applied as a fracture treatment.</description><identifier>ISSN: 0914-8779</identifier><identifier>EISSN: 1435-5604</identifier><identifier>DOI: 10.1007/s00774-017-0852-5</identifier><identifier>PMID: 28660377</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Bone growth ; Bone healing ; Bone resorption ; Callus ; Computed tomography ; Femur ; Fractures ; Medicine ; Medicine &amp; Public Health ; Metabolic Diseases ; Morphometry ; Original Article ; Orthopedics ; Osteoblasts ; Osteoclastogenesis ; Osteoclasts ; Osteogenesis ; Periosteum ; TRANCE protein</subject><ispartof>Journal of bone and mineral metabolism, 2018-07, Vol.36 (4), p.383-391</ispartof><rights>The Japanese Society for Bone and Mineral Research and Springer Japan KK 2017</rights><rights>Journal of Bone and Mineral Metabolism is a copyright of Springer, (2017). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c589t-82eae53e0634c188836910ec8e02f18698a6e20f82fa95106c9c597da6c6aa783</citedby><cites>FETCH-LOGICAL-c589t-82eae53e0634c188836910ec8e02f18698a6e20f82fa95106c9c597da6c6aa783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28660377$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sawa, Mikiya</creatorcontrib><creatorcontrib>Wakitani, Shigeyuki</creatorcontrib><creatorcontrib>Kamei, Naosuke</creatorcontrib><creatorcontrib>Kotaka, Shinji</creatorcontrib><creatorcontrib>Adachi, Nobuo</creatorcontrib><creatorcontrib>Ochi, Mitsuo</creatorcontrib><title>Local administration of WP9QY (W9) peptide promotes bone formation in a rat femur delayed-union model</title><title>Journal of bone and mineral metabolism</title><addtitle>J Bone Miner Metab</addtitle><addtitle>J Bone Miner Metab</addtitle><description>The WP9QY peptide (W9) consists of nine amino acids. It binds to RANKL and blocks RANKL-induced increases in bone resorption and osteoclastogenesis. W9 has a unique effect on the coupling mechanism between osteoclasts and osteoblasts, which promotes bone formation while working to suppress bone resorption. In this study, with the aim of clinical application of W9 for fracture treatment, we aimed to clarify the bone repair-promoting effect of W9 when administered locally to a rat femur model of delayed union. Using Sprague–Dawley rats, a model of delayed union was created in the right femur by cauterizing the periosteum. Injection of W9 (1 mg in 100 μl) or phosphate-buffered saline (PBS) (100 μl) at the fracture site was performed at the operation and every week thereafter until death (sacrifice). The bone union rate was 14% in the PBS group and 57% in the W9 group at 8 weeks postoperatively. The X-ray score of the W9 group was significantly higher than that of the PBS group at 8 weeks postoperatively. When bone morphometry was analyzed by micro-computed tomography (CT), total callus volume (TV) and mineralized callus bone volume (BV) were measured. TV showed no significant difference between the two groups, but BV/TV was significantly higher in the W9 group. This finding suggests that local administration of W9 can promote bone maturation from callus and can be considered to contribute to fracture healing. These results reveal that W9 has an effect on fractures of promoting healing and could be applied as a fracture treatment.</description><subject>Bone growth</subject><subject>Bone healing</subject><subject>Bone resorption</subject><subject>Callus</subject><subject>Computed tomography</subject><subject>Femur</subject><subject>Fractures</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic Diseases</subject><subject>Morphometry</subject><subject>Original Article</subject><subject>Orthopedics</subject><subject>Osteoblasts</subject><subject>Osteoclastogenesis</subject><subject>Osteoclasts</subject><subject>Osteogenesis</subject><subject>Periosteum</subject><subject>TRANCE protein</subject><issn>0914-8779</issn><issn>1435-5604</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kUtr3DAUhUVpaCaPH9BNEXSTLJReydZrWUKbBAaSQMOQlVDk6-JgW1PJXuTfR4OnLQSykRD3O0eXcwj5zOGCA-hvuRy6ZsA1AyMFkx_IiteVZFJB_ZGswPKaGa3tITnK-RkKKDX_RA6FUQoqrVcE1zH4nvpm6MYuT8lPXRxpbOnmzt4_0rONPadb3E5dg3Sb4hAnzPQpjkjbmIaF7kbqaVHSFoc50QZ7_4INm8fdcIjlfUIOWt9nPN3fx-Th549fl9dsfXt1c_l9zYI0dmJGoEdZIaiqDtwYUynLAYNBEC03yhqvUEBrROut5KCCDdLqxqugvNemOiZni29Z9c-MeXJDlwP2vR8xztnxEoiRAKIq6Nc36HOc01i2cwJUCUooqQvFFyqkmHPC1m1TN_j04ji4XQdu6cCVaN2uAyeL5sveeX4asPmn-Bt6AcQC5DIaf2P6__X7rq84po_Y</recordid><startdate>20180701</startdate><enddate>20180701</enddate><creator>Sawa, Mikiya</creator><creator>Wakitani, Shigeyuki</creator><creator>Kamei, Naosuke</creator><creator>Kotaka, Shinji</creator><creator>Adachi, Nobuo</creator><creator>Ochi, Mitsuo</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20180701</creationdate><title>Local administration of WP9QY (W9) peptide promotes bone formation in a rat femur delayed-union model</title><author>Sawa, Mikiya ; Wakitani, Shigeyuki ; Kamei, Naosuke ; Kotaka, Shinji ; Adachi, Nobuo ; Ochi, Mitsuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c589t-82eae53e0634c188836910ec8e02f18698a6e20f82fa95106c9c597da6c6aa783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Bone growth</topic><topic>Bone healing</topic><topic>Bone resorption</topic><topic>Callus</topic><topic>Computed tomography</topic><topic>Femur</topic><topic>Fractures</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic Diseases</topic><topic>Morphometry</topic><topic>Original Article</topic><topic>Orthopedics</topic><topic>Osteoblasts</topic><topic>Osteoclastogenesis</topic><topic>Osteoclasts</topic><topic>Osteogenesis</topic><topic>Periosteum</topic><topic>TRANCE protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sawa, Mikiya</creatorcontrib><creatorcontrib>Wakitani, Shigeyuki</creatorcontrib><creatorcontrib>Kamei, Naosuke</creatorcontrib><creatorcontrib>Kotaka, Shinji</creatorcontrib><creatorcontrib>Adachi, Nobuo</creatorcontrib><creatorcontrib>Ochi, Mitsuo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of bone and mineral metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sawa, Mikiya</au><au>Wakitani, Shigeyuki</au><au>Kamei, Naosuke</au><au>Kotaka, Shinji</au><au>Adachi, Nobuo</au><au>Ochi, Mitsuo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Local administration of WP9QY (W9) peptide promotes bone formation in a rat femur delayed-union model</atitle><jtitle>Journal of bone and mineral metabolism</jtitle><stitle>J Bone Miner Metab</stitle><addtitle>J Bone Miner Metab</addtitle><date>2018-07-01</date><risdate>2018</risdate><volume>36</volume><issue>4</issue><spage>383</spage><epage>391</epage><pages>383-391</pages><issn>0914-8779</issn><eissn>1435-5604</eissn><abstract>The WP9QY peptide (W9) consists of nine amino acids. It binds to RANKL and blocks RANKL-induced increases in bone resorption and osteoclastogenesis. W9 has a unique effect on the coupling mechanism between osteoclasts and osteoblasts, which promotes bone formation while working to suppress bone resorption. In this study, with the aim of clinical application of W9 for fracture treatment, we aimed to clarify the bone repair-promoting effect of W9 when administered locally to a rat femur model of delayed union. Using Sprague–Dawley rats, a model of delayed union was created in the right femur by cauterizing the periosteum. Injection of W9 (1 mg in 100 μl) or phosphate-buffered saline (PBS) (100 μl) at the fracture site was performed at the operation and every week thereafter until death (sacrifice). The bone union rate was 14% in the PBS group and 57% in the W9 group at 8 weeks postoperatively. The X-ray score of the W9 group was significantly higher than that of the PBS group at 8 weeks postoperatively. When bone morphometry was analyzed by micro-computed tomography (CT), total callus volume (TV) and mineralized callus bone volume (BV) were measured. TV showed no significant difference between the two groups, but BV/TV was significantly higher in the W9 group. This finding suggests that local administration of W9 can promote bone maturation from callus and can be considered to contribute to fracture healing. These results reveal that W9 has an effect on fractures of promoting healing and could be applied as a fracture treatment.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>28660377</pmid><doi>10.1007/s00774-017-0852-5</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0914-8779
ispartof Journal of bone and mineral metabolism, 2018-07, Vol.36 (4), p.383-391
issn 0914-8779
1435-5604
language eng
recordid cdi_proquest_miscellaneous_1914850023
source Springer Nature
subjects Bone growth
Bone healing
Bone resorption
Callus
Computed tomography
Femur
Fractures
Medicine
Medicine & Public Health
Metabolic Diseases
Morphometry
Original Article
Orthopedics
Osteoblasts
Osteoclastogenesis
Osteoclasts
Osteogenesis
Periosteum
TRANCE protein
title Local administration of WP9QY (W9) peptide promotes bone formation in a rat femur delayed-union model
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T15%3A40%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Local%20administration%20of%20WP9QY%20(W9)%20peptide%20promotes%20bone%20formation%20in%20a%20rat%20femur%20delayed-union%20model&rft.jtitle=Journal%20of%20bone%20and%20mineral%20metabolism&rft.au=Sawa,%20Mikiya&rft.date=2018-07-01&rft.volume=36&rft.issue=4&rft.spage=383&rft.epage=391&rft.pages=383-391&rft.issn=0914-8779&rft.eissn=1435-5604&rft_id=info:doi/10.1007/s00774-017-0852-5&rft_dat=%3Cproquest_cross%3E1914850023%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c589t-82eae53e0634c188836910ec8e02f18698a6e20f82fa95106c9c597da6c6aa783%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2061752657&rft_id=info:pmid/28660377&rfr_iscdi=true